Skip Navigation

Health

Skip Side Navigation

Health-related Funding Opportunities

SAMHSA Announces Funding for Three Centers of Excellence for Behavioral Health Disparities
Proposals due August 19, 2020
The Substance Abuse and Mental Health Services Administration (SAMHSA) issued an FOA for Centers of Excellence for Behavioral Health Disparities to develop best practices, provide technical assistance, and support training approaches for healthcare practitioners on how to better address behavioral health disparities.  Each COE will focus on addressing behavioral health disparities among one of three key populations identified by SAMHSA: African Americans, the LGBTQ community, and the aging population (age 60 and over).  

NIH Solicits applications for the Director's Early Independence Award
Applications due September 4, 2020
The NIH Director’s Early Independence Award supports exceptional junior investigators pursuing independent research careers soon after completion of their formal training to accelerate their entry into an independent research career. This award will support 5 to 10 Early Independence Awards focused on any relevant area of coronavirus SARS- CoV-2 research.

AHRQ issues Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)
Applications accepted through September 26, 2020
This FOA aims to support applications for innovative collaborative investigations to understand how new health IT strategies can increase the utilization of PROs in ambulatory care settings and contribute to improved patient-centered health outcomes and quality of care. 

NIH Solicits applications for the Director's Transformative Research Award Program
Applications due September 30, 2020
The NIH Director’s Transformative Research Award Program supports research proposing groundbreaking, innovative, and original research to create new and improved clinical approaches and develop transformative technology. This award will support 5 to 10 Transformative Research Awards focused on any relevant area of coronavirus SARS-CoV-2 research.

Rolling Deadline:

Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) established a Commercial Solution Opening (CSO)
Solution briefs are accepted on a rolling basis through September 30, 2020
The DAF ACT seeks innovative solutions for commercial technologies that can “provide relief, resilience, recovery, and stability to the nation in response to the COVID-19 pandemic.” DAF ACT Areas of Interest include: Combating the Spread; Welfare of citizens; Readiness; Logistics; and Medical.

National Heart, Lung, and Blood Institute (NHLBI) issued a NOSI for COVID-19
Applications accepted on a Rolling Basis through October 6, 2020
Topics of specific interest include host response; associations with heart, lunch and blood diseases; potential impacts on transfusion safety; and clinical outcomes of infected individuals.

NOSI: Availability of Supplements for Research on Stress Management in Relation to COVID-19
Applications accepted on a Rolling Basis through October 6, 2020
Topics of specific interest for this NOSI include research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.

Biomedical Advanced Research and Development Authority (BARDA) at the Department of Health and Human Services (HHS) released an Easy Broad Agency Announcement for COVID-19 Diagnostics
White papers are accepted on a Rolling basis through October 31, 2020
BARDA seeks proposals for COVID-19 diagnostics that use "platforms already cleared by the U.S. Food and Drug Administration (FDA), with a viable plan to meet requirements for the FDA to consider an Emergency Use Authorization within 12 weeks of an award. Full proposals may be invited based on the submitted White Paper.

PA-18-793: AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
Applications accepted three times a year through January 25, 2021
AHRQ solicits applications for Large Research Demonstration and Dissemination projects that focus on the AHRQ mission of producing evidence to make health care safer, higher quality, more ac­cessible, equitable and affordable, and working with HHS and other partners to make sure that the evidence is understood and used.  Within the mission, AHRQ’s specific priority areas of focus are: 1) Research to improve health care patient safety. 2) Harnessing data and technology to improve health care quality and patient outcomes and to provide a 360-degree view of the patient. and 3) Research to increase accessibility and affordability of health care by examining innovative market approaches to care delivery and financing.

National Institute of Allergy and Infectious Disease (NIAID) COVID-19 Funding
Proposals accepted on a Rolling basis through February 6, 2021
NIAID using noncompetitive administrative supplements and competitive Urgent Awards to disperse $826 million in emergency funding.

National Institute of General Medical Sciences (NIGMS) issued NOSI for SARS-CoV-2 virus
Applications accepted on a Rolling Basis through February 6, 2021
NIGMS solicits competitive revisions that address: "incorporation of data related to SARS-CoV-2 into ongoing research efforts to develop predictive models for the spread of SARS-CoV-2 and other related infectious agents; repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR only); rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR only)."

NOSI: Supplements for Mental Health Research related to the 2019 Novel Coronavirus
Applications accepted on a Rolling Basis through April 15, 2021
National Institute of Mental Health (NIMH) seeks research that provides evidence for how a disrupted workforce may adequately respond, adapt, and maintain services or provide additional care for new or increasing mental health needs.

NIAID issues a Notice of Special Interest (NOSI) for the Availability of Emergency Competitive Revisions for Research on SARS-CoV-2 and COVID-19
Applications accepted on a Rolling Basis through March 25, 2021
The NOSI details NIAID's research priorities and urgent need for projects focused on viral natural history, pathogenicity, transmission, and projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics. Applications can request Administrative Supplements and Emergency Competitive Revisions

National Institute on Drug Abuse (NIDA) issued a NOSI for COVID-19 to collect/examine data for individuals suffering from substance use disorders (SUD)
Applications accepted on a Rolling Basis through March 31, 2021
This NOSI mentions topics of specific interest including respiratory effects of COVID-19 among individuals with SUD, drug-drug interaction of medication to treat COVID-19 and substances of abuse or medications to treat SUDs.

NOSI: Supplements for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
Applications accepted on a Rolling Basis through March 31, 2021
This NOSI encourages supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts.

NOSI: Supplements on COVID-19 within the Mission of National Institute on Alcohol Abuse and Alcoholism (NIAAA) 
Applications accepted on a Rolling Basis through April 15, 2021
This NOSI encourages applications to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes.

DARPA Biological Technologies Office (BTO) Releases 2020 BAA
Abstracts and proposals accepted on a Rolling Basis through April 22, 2021
DARPA BTO seeks innovative science research through their 2020 BAA on topics including: 1) “Designing novel materials, sensors, or processes that mimic or are inspired by biological systems. 2) Developing new technologies for advanced eukaryotic cellular engineering to support next-generation cellular therapeutic applications. 3) Developing new platform technologies for targeted, effective, spatiotemporally-controlled delivery of large and small molecules and biologics. 4) Developing tools to understand the underlying rules defining biomolecular and biomaterial structure/function properties in order to predict desired outcomes for novel materials. and 5) Leveraging biological systems to produce solutions for antimicrobial resistance.”

NIH National Institute on Aging (NIA) issued a Notice of Special Interest (NOSI) related to COVID-19 crisis
Administrative Supplements and Competitive Revision Applications accepted on a rolling basis through May 1, 2021
NIA requests applications for research interests relevant to work within Divisions of Aging Biology, Neuroscience, Geriatrics and Clinical Gerontology, and Behavioral and Social Research. The National Institute of Mental Health (NIMH) is also accepting applications to existing NIMH grants that focus on "how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs in midlife and older age adults."

NOSI: Supplements to Study the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
Applications accepted on a Rolling Basis through May 1, 2021
Research is solicited in health disparity populations that -seeks to understand: 1) how state and local policies and initiatives mitigate or exacerbate disparities in health services use and health outcomes; 2) the role that community-level protective and resilience factors and interventions have in mitigating the effects of the sector disruptions that the COVID-19 outbreak causes; and 3) how behavioral and/or biological mechanisms may contribute to COVID-19 manifestations.

NOSI: NIEHS seeks to understand the impact of Environmental Exposures on 2019 Coronavirus
Applications accepted on a monthly basis through May 2021
The National Institute of Environmental Health Sciences (NIEHS) seeks to understand the potential contributions of current and past exposure to environmental agents that may exacerbate COVID-19 susceptibility, disease severity, and progression. Environmental exposures include toxic chemicals, air pollutants, second hand tobacco smoke, e-cigarette vapors, and metals that may impact health outcomes. In addition, some health outcomes that are linked to environmental exposures (asthma, diabetes, and other pulmonary, cardiovascular, and metabolic diseases) are also risk factors for COVID-19. Funding through Supplements or Time-Sensitive Research (R21).

NIAID Announces R01 Emergency Awards: Rapid Investigation of SARS-CoV-2 and COVID-19
R21 funding mechanism also available
Applications accepted on a Rolling Basis through April 30, 2021
NIAID intends to provide expedited funding for research on SARS-CoV-2 and COVID-19. Areas of high priority include: understanding critical aspects of viral infection/replication; critical aspects of viral transmission; development and testing of SARS-CoV-2 therapeutic candidates; and development of vaccination strategies for at-risk populations.

NIH Announces Rapid Acceleration of Diagnostics (RADx) program
Proposals accepted on a Rolling Basis (June 30, 2021)
The RADx program fast-tracks COVID-19 test development and distribution and will leverage the existing Point-of-Care Technology Research Network to support novel solutions to ramp up national capacity for SARS- CoV-2 testing. The RADx program will support all phases of product development from conceptualization and design through manufacturing.

Patient-Centered Outcomes Research Institute (PCORI) Solicits COVID-19 Enhancements to Existing PCORI-Funded Projects
Applications accepted on a Rolling Basis until no longer relevant (June 2021?)
PCORI seeks to support work for COVID-19 related dilemmas facing patients, caregivers, providers, health systems, and policymakers through targeted investments in extending our Research, Engagement Awards, and Dissemination and Implementation activities.

AHRQ solicits Large Research Projects to Improve Healthcare
Applications accepted Three times a year through July 5, 2021
This FOA solicits Large Research (R01) Project applications that focus on producing evidence to make health care safer, higher quality, more ac­cessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used.  The specific priority areas of focus are: 1) Research to improve health care patient safety, 2) Harnessing data and technology to improve health care quality and patient outcomes and to provide a 360-degree view of the patient, and 3) Research to increase accessibility and affordability of health care by examining innovative market approaches to care delivery and financing.

National Center for Advancing Translational Sciences (NCATS) issued a NOSI for COVID-19
Applications accepted from May 4, 2020 through July 10, 2021
Research priorities include "use of informatics solutions to diagnose cases and the use of CTSA-supported core resources to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines." Awards can be made through Administrative Supplements, Collaborative Innovation Awards, and Competitive Revisions.

NOSI: Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
Applications accepted on a Rolling Basis through January 25, 2022
NCATS solicits research that uses microphysiological systems or tissue chips for collecting and examining data on the risks and outcomes of COVID-19 infection, in order to advance the translation of research findings into diagnostics, therapeutics, and vaccines.

PA-17-232: AHRQ Solicits Mentored Clinical Scientist Research Career Development Award (K08) Applications
Applications accepted Three Times a Year through July 12, 2022
The Mentored Clinical Scientist Research Career Development Award supports didactic study and/or mentored research opportunities in health services research, for individuals with clinical doctoral degrees (e.g., MD, DDS, DMD, DO, DC, OD, ND, DVM, PharmD, or PhD in clinical disciplines) through the provision of salary and research support over a sustained period of “protected time” (3-5 years).  The expectation is that, through this sustained period of research career development and training, awardees will launch independent research careers and become competitive for new research project grant (e.g., R01) funding.

PA-17-481: AHRQ solicits National Research Service Award (NRSA) Individual  Postdoctoral Fellowship (F32) Applications
Applications accepted Three Times a Year through August 8, 2022
The overall goal of the AHRQ-sponsored Ruth L. Kirschstein National Research Service Award (NRSA) program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's  health services research and  behavioral research needs.  Applications for research fellowship grants must be responsive to AHRQ's mission, which is to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work within HHS and with other partners to make sure that the evidence is understood and used.

PA-16-422: Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R18)
Applications accepted three times a year through September 25, 2021
This Funding Opportunity Announcement (FOA) solicits applications for grant funding to conduct Large Health Services Research Demonstration and Dissemination Projects (R18) focused on Combating Antibiotic-Resistant Bacteria (CARB) in the following ways: by promoting appropriate antibiotic use, reducing the transmission of resistant bacteria, and preventing healthcare-associated infections (HAIs) in the first place.

PA-20-028: Medication Safety:  Advancing the Development of Improvement Strategies and Tools (R18) 
Applications accepted three times a year through September 25, 2022
This funding opportunity continues AHRQ's support of medication safety investigator-initiated research projects. Medication safety research should not only address the prevention of harm, but also promote standardized and optimized practices and behaviors.  AHRQ will focus on funding grants that have strong patient safety impact potential and address significant patient safety problems that result in patient harm or mortality, occur with high frequency, and entail a high cost burden.

PA-20-067: AHRQ Solicits Applications for Mentored Research Scientist Career Development Award (K01)
Applications accepted Three Times a Year through November 13, 2022
The AHRQ Mentored Research Scientist Career Development Awards (K01) program helps ensure that a diverse pool of highly trained scientists are available in appropriate scientific disciplines to address the Nation's health services research needs. This AHRQ program provides support and “protected time” to individuals with a research doctoral degree for an intensive, supervised research career development experience in health services research.  The K01 award can be used both by individuals who propose to newly embark in heath services research training and those who had a hiatus in their research careers because of illness or family circumstances. 

NIH Solicits New National Centers for Biomedical Imaging and Bioengineering (NCBIB)
Annually: January 25, May 25, September 25 through 2023
This P41 biotechnology resource grant program solicitation intends to establish National Centers for Biomedical Imaging and Bioengineering (NCBIB) to accelerate the development and dissemination of new biomedical technology. Centers will have central Technology Research and Development projects; engage in Collaborative Projects that serve as technology drivers, users and testbeds for technology developed in TR&D projects, and Service Projects that serve as users of the well-developed and stable technologies of the Center.

HHS BARDA EZ-BAA: COVID-19 from February 5, 2020
Applications accepted on a Rolling Basis through February 3, 2023
Proposals for COVID-19 diagnostics that "utilize platforms already cleared by US FDA, with a viable plan to meet requirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeks of award."

PA-18-765: AHRQ Solicits Applications to the Health Services Research Dissertation Program (R36)
Applications accepted Quarterly through May 1, 2023
Applications for dissertation research grants must be responsive to AHRQ’s mission, which is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work with the U.S. Department of Health and Human Services (HHS) and other partners to make sure that the evidence is understood and used.  Candidates are encouraged to address health services research issues critical to AHRQ priority populations, including: individuals living in inner city or rural (including frontier) areas; low-income and minority groups; women, children, the elderly; and individuals with special health care needs, including those with disabilities and those who need chronic or end-of-life health care.

PAR-18-798: NIOSH Seeks Applications for the Exploratory/Developmental Grant Program (R21)
Applications accepted Three Times a Year through November 17, 2023
NIOSH supports exploratory and developmental research projects (R21) that identify and address novel scientific ideas or new model systems, tools, or technologies with the potential for significant impact on occupational safety and health. The R21 grant program seeks to (1) develop an understanding of the risks and conditions associated with occupational diseases and injuries, (2) explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and (3) translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.

PAR-18-799: NIOSH Solicits Mentored Research Scientist Development Award (K01) Applications
Applications accepted Three Times a Year through November 17, 2023
The K01 grant mechanism provides "protected time" for an intensive, supervised (mentored) career development experience in occupational health and safety research. This can facilitate the transition of junior research scientists from the mentored to the independent stages of their careers in occupational health and safety research. NIOSH supports research objectives such as the following: 1) Identification and investigation of the relationships between hazardous working conditions and associated occupational diseases and injuries; 2) development of new protective equipment and engineering control technology to reduce work-related illnesses and injuries; and 3)evaluation of the technical feasibility or application of new or improved occupational safety and health procedures, methods, techniques, or systems, including assessment of economic and other factors that influence their diffusion and successful adoption in workplaces.

In-Q-Tel interested in COVID-19 related technology innovations
Rolling
In-Q-Tel works to accelerate the development of cutting edge "ready-soon" technologies. Specific technologies sought to combat COVID-19 include: point-of-care diagnostics; swabs for sample collection; serological diagnostics; and digital self-triage capabilities for telehealth. 

HHS BARDA: CoronaWatch Accepting Technology Acceleration Applications
Applications accepted on a Rolling Basis
CoronaWatch used to accelerate technologies related to COVID-19
Specific submission options for therapeutics, vaccines, diagnostics, and other products.

Department of Energy releases Dear Colleague Letter soliciting ideas to address COVID-19
Applications accepted on a Rolling basis
DOE encourages the scientific community and others to consider research questions that underpin COVID-19 response and requests input on strategic, priority research directions that may be undertaken using DOE user facilities, computational resources, and enabling infrastructure.

NIH National Human Genome Research Institute (NHGRI) issues Notice of Special Interest (NOSI) to better understand SARS-CoV2
Competitive Revision Applications accepted on a Rolling Basis
This solicitation focuses on better understanding host response, associated diseases, and short- and long-term clinical outcomes of infected individuals. Interest include development of novel methods using genomic techniques to identify signatures of infection, prognosis, and severity of disease; development of novel genomic-based tools, kits or reagents to track/monitor infected individuals; and use of tools to understand genetic epidemiology of SARS-CoV-2.

Anticipated:

NIH releases NOI for RADx funding programs
Anticipated deadlines starting in September 2020
The National Institutes of Health (NIH) intends to publish multiple funding opportunity announcements for the Rapid Acceleration of Diagnostics for Radical (RADx-rad) program from July 17-31, 2020 on topics listed below. The RADx-rad program was created to support innovative and non-traditional approaches to rapid diagnostics and home-based testing technologies. 
1. Wastewater detection of SARS-CoV-2 (COVID-19) 
2. Exosome-based non-traditional technologies toward multi-parametric and integrated approaches for SARS-CoV-2
3. Chemosensory testing as a COVID-19 screening tool
4. Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds)
5. Multimodal COVID-19 surveillance methods for High Risk Populations in densely populated facilities
6. Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and The Oral Cavity
7. Automatic detection and tracing of SARS-CoV-2

NOI for NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program Cohort
Anticipated Application Deadline of November 9, 2020 
The FIRST program is designed to support institutions in developing and implementing faculty cohort models that will advance the hiring of diverse groups of research faculty. FOA to be released September 9, 2020.

NOI for NIH FIRST Coordination and Evaluation Center 
Anticipated Application Deadline of November 9, 2020
The Coordination and Evaluation Center (CEC) will be tasked with facilitating the awarded institutions into an organized consortium in addition to developing evaluation strategies, metrics, and datasets.  The CEC will be responsible for evaluating the success of the whole program, rather than individual awardees.  In addition, the CEC will help to identify and disseminate evidence-based strategies for nationwide adoption. FOA to be released September 9, 2020.

DOD Army MTEC likely to release further COVID-19 RFPs 
Anticipated
RFPs for other topics are anticipated including: Point of care diagnostics, prophylactics/therapeutics that can prevent/treat rapidly in a non-hospital environment, disease predictive modeling, patient monitoring, tracking and management system.

Health-related engagement opportunities:

NIH Issues New Guidance Designed to Combat Sexual Harassment 
Guidance – Archive September 2020
NIH has issued Notice OD-20-124 to clarify the agency’s expectation for reporting when there has been a change in the status of key grant personnel related to findings of sexual harassment.  While NIH has previously required notification and prior approval before grantee institutions made any change to the status of PIs or other senior/key personnel on grants, this new guidance specifically states that when seeking approval for status changes, requests should “mention as to whether change(s) in PD/PI or Senior/Key Personnel is related to concerns about safety and/or work environments (e.g. due to concerns about harassment, bullying, retaliation, or hostile working conditions).”

NIAID Releases 2020-2024 Strategic Plan for COVID-19
For informational purposes
NIAID’s Strategic Plan is to “conduct and support research on SARS‐CoV‐2 and COVID‐19 to accelerate the development of safe and effective medical countermeasures that decrease disease incidence, mitigate morbidity and prevent mortality.” Four research priority pillars include: 1) Improve knowledge and understanding of SARS-CoV-2 and COVID-19; 2) Develop diagnostics and assays to identify and isolate COVID-19 cases; 3) Characterize and test potential therapeutics and treatments for COVID-19; and 4) Develop effective vaccines to combat SARS-CoV-2.

NIH releases the “2020-2030 Strategic Plan for NIH Nutrition Research.”  
Archive June 10, 2021
This NIH-wide strategic plan for nutrition research signals NIH’s intention to invest more strategically in nutrition research to advance understanding of the many ways diet interacts with health and disease. The plan has four strategic goals:
1) “Spur Discovery and Innovation through Foundational Research: What do we eat and how does it affect us?
2) Investigate the Role of Dietary Patterns and Behaviors for Optimal Health: What and when should we eat?
3) Define the Role of Nutrition Across the Lifespan: How does what we eat promote health across our lifespan?
4) Reduce the Burden of Disease in Clinical Settings: How can we improve the use of food as medicine?”